ZIOPHARM Oncology Inc (NASDAQ:ZIOP)
| 3.43 Delayed Data As of Apr 14 |  +0.07 / +2.07%Today’s Change | 2.06 Today|||52-Week Range 5.95 | +36.11% Year-to-Date |
Latest ZIOP News | Press Releases
No recent news for ZIOPHARM Oncology Inc.
Today’s Trading
| Previous close | 3.38 |
| Today’s open | 3.34 |
| Day’s range | 3.34 - 3.60 |
| Volume | 1,536,742 |
| Average volume (3 months) | 2,697,842 |
| Market cap | $714.5M |
Data as of 3:59pm ET, 04/14/2021
Growth & Valuation
| Earnings growth (last year) | +45.61% |
| Earnings growth (this year) | -17.11% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 5.75 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VBIVVBI Vaccines Inc | +0.04 | +1.40% |
| CGENCompugen Ltd | -0.06 | -0.69% |
| ---- | ||
| ADAPAdaptimmune Therapeu... | -0.03 | -0.59% |
Data as of 3:59pm ET, 04/14/2021
Financials
| Next reporting date | May 13, 2021 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$80.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
